Diabetes, Digestive, and Kidney Diseases Extramural Research in Minnesota
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $291 million to recipients in Minnesota in 237 grants from fiscal 2021 to 2025, 3.0% of the program's national total. Mayo Clinic received the most, $169 million.
- Awarded in Minnesota$291 million
- Awards237
- Share of the program3.0%
- Rank among states12th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 124 | $48.7 million |
| FY 2022 | 125 | $51.9 million |
| FY 2023 | 136 | $58.3 million |
| FY 2024 | 136 | $59.1 million |
| FY 2025 | 134 | $73.0 million |
Recipients in Minnesota
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Mayo Clinic | Nonprofits | 133 | $169 million |
| Regents of the University of Minnesota | Colleges and universities | 82 | $97.8 million |
| Healthpartners Institute | Nonprofits | 2 | $5.8 million |
| Hennepin Healthcare Research Institute | Nonprofits | 7 | $4.1 million |
| Koronis Biomedical Technologies Corp. | Small businesses | 2 | $3.2 million |
| Aplos Medical Inc | Small businesses | 2 | $2.2 million |
| Phenomix Sciences LLC | Small businesses | 1 | $2.0 million |
| Fistula Solution Corporation | Small businesses | 1 | $1.9 million |
| Innovative Design Labs Inc | Small businesses | 1 | $1.5 million |
| Emmyon, Inc. | Small businesses | 1 | $1.0 million |
Open opportunities under this program
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
See all 68 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Minnesota?
$291 million from fiscal 2021 to 2025, across 237 awards. Minnesota ranks 12th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Minnesota?
The largest recipient is Mayo Clinic, with $169 million in 133 awards. Next are Regents of the University of Minnesota and Healthpartners Institute.
Can organizations in Minnesota apply now?
Yes, 68 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Minnesota
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Federal Transit Capital Investment Grants
- Special Education Grants to States
- Child Care and Development Block Grant
- Federal Transit Formula Grants
- Affordable Rural Cooperative